BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Circadian Technologies Limited 

Rialto Towers, Level 23
525 Collins Street
Victoria    3000  Australia
Phone: 61-03-9826-0399 Fax: 61-03-9826-0083


SEARCH JOBS








 Company News
Circadian Technologies Limited (CIR.AX) Commences First Phase 1 Clinical Trial of VEGF-C Antibody VGX-100 in Cancer Patients 1/9/2012 10:19:05 AM    More...
Circadian Technologies Limited (CIR.AX) Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors 10/31/2011 11:22:35 AM    More...
Circadian Technologies Limited (CIR.AX) Files IND With FDA for VGX-100 for the Treatment of Cancer Patients With Solid Tumors 9/30/2011 10:16:24 AM    More...
Circadian Technologies Limited (CIR.AX) Release: VGX-100 Identified as Potential New Therapy for Dry Eye Disease 9/13/2011 11:38:21 AM    More...
Merriman Capital Announces Sponsorship of Circadian Technologies Limited (CIR.AX) on OTCQX 6/14/2011 9:00:25 AM    More...
Circadian Technologies Limited (CIR.AX) Release: VEGF-C and VEGF-D Identified as Biomarkers for Avastin Resistance in Colorectal Cancer Patients 6/7/2011 8:23:13 AM    More...
Circadian Technologies Limited (CIR.AX)'s VGX-100 Inhibits Tumour Growth in Models of Lung, Ovarian and Prostate Cancer 4/6/2011 7:35:03 AM    More...
Circadian Technologies Limited (CIR.AX)'s Partner ImClone Systems Corporation (IMCL) Commences First Phase 1 Clinical Trial of VEGFR-3 Antibody IMC-3C5 4/6/2011 7:32:51 AM    More...
Circadian Technologies Limited (CIR.AX) Launches First Diagnostic for LAM Lung Disease With U.S. Partner 2/2/2011 7:58:50 AM    More...
Circadian Technologies Limited (CIR.AX) Launches First Diagnostic for LAM Lung Disease With U.S. Partner 2/2/2011 7:09:18 AM    More...
123

//-->